Literature DB >> 15522012

High seroprevalence of Pneumocystis infection in Spanish children.

N Respaldiza1, F J Medrano, A C Medrano, J M Varela, C de la Horra, M Montes-Cano, S Ferrer, I Wichmann, D Gargallo-Viola, E J Calderon.   

Abstract

Pneumocystis infection occurs worldwide, and most individuals test seropositive for Pneumocystis early in childhood. Little is known about the epidemiology of this infection in western Europe. The seroprevalence of Pneumocystis infection in 233 Spanish children was determined in a community study by immunoblot analysis of sera. The overall seroprevalence was 73%, with an age-related increase from 52% at 6 years to 66% at 10 years and 80% at 13 years. The data indicated a high seroprevalence of Pneumocystis infection in healthy Spanish children, thereby demonstrating that this pathogen is widespread in southern Spain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522012     DOI: 10.1111/j.1469-0691.2004.00974.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  28 in total

1.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  High transient colonization by Pneumocystis jirovecii between mothers and newborn.

Authors:  Cristian Vera; Yudy A Aguilar; Lázaro A Vélez; Zulma Vanessa Rueda
Journal:  Eur J Pediatr       Date:  2017-09-14       Impact factor: 3.183

Review 4.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

5.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity.

Authors:  John W Wilson; Andew H Limper; Thomas E Grys; Theresa Karre; Nancy L Wengenack; Matthew J Binnicker
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

6.  Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity.

Authors:  Taylor Eddens; Waleed Elsegeiny; Maria de la Luz Garcia-Hernadez; Patricia Castillo; Giraldina Trevejo-Nunez; Katelin Serody; Brian T Campfield; Shabaana A Khader; Kong Chen; Javier Rangel-Moreno; Jay K Kolls
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

Review 7.  Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond.

Authors:  Richard J Wang; Robert F Miller; Laurence Huang
Journal:  Clin Chest Med       Date:  2017-06-03       Impact factor: 2.878

8.  Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.

Authors:  Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.